oru.sePublications
Change search
Refine search result
1 - 2 of 2
CiteExportLink to result list
Permanent link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Rows per page
  • 5
  • 10
  • 20
  • 50
  • 100
  • 250
Sort
  • Standard (Relevance)
  • Author A-Ö
  • Author Ö-A
  • Title A-Ö
  • Title Ö-A
  • Publication type A-Ö
  • Publication type Ö-A
  • Issued (Oldest first)
  • Issued (Newest first)
  • Created (Oldest first)
  • Created (Newest first)
  • Last updated (Oldest first)
  • Last updated (Newest first)
  • Disputation date (earliest first)
  • Disputation date (latest first)
  • Standard (Relevance)
  • Author A-Ö
  • Author Ö-A
  • Title A-Ö
  • Title Ö-A
  • Publication type A-Ö
  • Publication type Ö-A
  • Issued (Oldest first)
  • Issued (Newest first)
  • Created (Oldest first)
  • Created (Newest first)
  • Last updated (Oldest first)
  • Last updated (Newest first)
  • Disputation date (earliest first)
  • Disputation date (latest first)
Select
The maximal number of hits you can export is 250. When you want to export more records please use the Create feeds function.
  • 1.
    Petyaev, Ivan M.
    et al.
    Lycotec Ltd, Cambridge, UK.
    Dovgalevsky, Pavel Y.
    Institute of Cardiology, Saratov, Russia.
    Klochkov, Victor A.
    Institute of Cardiology, Saratov, Russia.
    Chalyk, Natalya E.
    Institute of Cardiology, Saratov, Russia.
    Pristensky, Dmitry V.
    Lycotec Ltd, Cambridge, UK.
    Chernyshova, Marina P.
    Lycotec Ltd, Cambridge, UK.
    Udumyan, Ruzan
    Örebro University, School of Medical Sciences.
    Kocharyan, Taron
    Örebro University Hospital and School of Health and Medical Sciences, Örebro University, Örebro, Sweden.
    Kyle, Nigel H.
    Lycotec Ltd, Cambridge, UK.
    Lozbiakova, Marina V.
    Lycotec Ltd, Cambridge, UK.
    Bashmakov, Yuriy K.
    Lycotec Ltd, Cambridge, UK.
    Effect of lycopene supplementation on cardiovascular parameters and markers of inflammation and oxidation in patients with coronary vascular disease2018In: Food Science & Nutrition, E-ISSN 2048-7177, Vol. 6, no 6, p. 1770-1777Article in journal (Refereed)
    Abstract [en]

    Oxidative stress and antioxidant deficiency play a pivotal role in initiation, development, and outcomes of cardiovascular disease. Pharmacokinetic parameters as well as the impact of highly bioavailable lycopene on cardiovascular variables, markers of inflammation and oxidation were investigated during a 30-day clinical trial in patients with coronary vascular disease. The patients were randomized into two major groups and were supplemented with a single 7mg daily dose of lycopene ingested either in the form of lactolycopene (68 patients) or in the form of lycosome-formulated GA lycopene (74 patients). The endpoints included cardiovascular function parameters, serum lipids, and four markers of oxidative stress and inflammation. Ingestion of lycosome-formulated lycopene increased serum lycopene levels by 2.9- and 4.3-fold, respectively, after 2 and 4weeks of the trial, whereas supplementation with lactolycopene upregulated serum lycopene by half-fold only after 4weeks of ingestion. Lycosome formulation of lycopene resulted by the end of the trial in a threefold reduction in Chlamydia pneumoniae IgG and reduction to the same degree of the inflammatory oxidative damage marker. The decrease in oxidized LDL caused by lycosome-formulated lycopene was fivefold. Moreover, supplementation with lycosome-formulated lycopene was accompanied by a significant increase in tissue oxygenation and flow-mediated dilation by the end of the observational period. In contrast, lactolycopene did not cause any significant changes in the parameters studied. Therefore, enhanced bioavailability of lycopene promotes its antioxidant and anti-inflammatory functions and endorses a positive effect of lycopene on cardiovascular system.

  • 2.
    Petyaev, Ivan M.
    et al.
    Lycotec Ltd, Cambridge, UK.
    Dovgalevsky, Pavel Y.
    Institute of Cardiology, Saratov, Russia.
    Klochkov, Victor A.
    Institute of Cardiology, Saratov, Russia.
    Chalyk, Natalya E.
    Institute of Cardiology, Saratov, Russia.
    Pristensky, Dmitry V.
    Lycotec Ltd, Cambridge, UK.
    Chernyshova, Marina P.
    Lycotec Ltd, Cambridge, UK.
    Udumyan, Ruzan
    Örebro University, School of Medical Sciences.
    Kocharyan, Taron
    Örebro University Hospital and School of Health and Medical Sciences, Örebro University, Örebro, Sweden.
    Kyle, Nigel H.
    Lycotec Ltd, Cambridge, UK.
    Lozbiakova, Marina V.
    Lycotec Ltd, Cambridge, UK.
    Bashmakov, Yuriy K.
    Lycotec Ltd, Cambridge, UK.
    Effect of lycopene supplementation on cardiovascular parameters and markers of inflammation and oxidation in patients with coronary vascular disease (vol 6, pg 1770, 2018)2019In: Food Science & Nutrition, E-ISSN 2048-7177, Vol. 7, no 4, p. 1551-1551Article in journal (Refereed)
1 - 2 of 2
CiteExportLink to result list
Permanent link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf